G Square Healthcare PE

About G Square Healthcare PE

G Square Healthcare Private Equity is one of Europe's only pure-play healthcare PE specialists with approximately $4.0 billion (~€3.7 billion) of assets under management as of December 2024, headquartered in London. The firm was founded in 2008 as a UK healthcare-specialist PE firm and operates as a partner-owned Limited Liability Partnership with approximately 32 professionals, a UN PRI signatory since 2012. G Square raised an approximately €500 million continuation vehicle in 2024 to extend control of two legacy funds.

Investment thesis

G Square Healthcare deploys capital through approximately five funds (GSC I, II, III, IV plus a continuation vehicle), targeting mid-market control buyouts in healthcare with hands-on growth acceleration and buy-and-build. Sector focus spans healthcare services, medical products and devices, medtech distribution, digital health, diagnostics and pharma services. Geographic deployment is pan-European core (UK, Benelux, Italy, Nordics, DACH) with selective global expansion of portfolio companies. The platform pairs deep sector knowledge with operational buy-and-build expertise.

Recent activity

Recent realised exits include medtech distribution (2024). Recent acquisitions include biomaterials and orthopaedics (2025), surgical fluid management (2026) and healthcare services pharmacy (2026). The platform continues active deployment across the pan-European healthcare mandate. Detailed buyer names and multiple data available on Pro at €29/month.